Keyphrases
Parkinson's Disease
100%
Non-associated
100%
Inflammatory Markers
100%
Leucine-rich Repeat Kinase 2 (LRRK2)
100%
Non-manifesting Carriers
50%
Inflammation
37%
Idiopathic Parkinson's Disease
37%
Parkinson Patients
25%
Cerebrospinal Fluid
25%
Healthy Controls
12%
Peripheral Blood
12%
Interleukin-8
12%
Homozygote
12%
Mutation Carriers
12%
Disease Pattern
12%
Ashkenazi Jews
12%
Neurodegeneration
12%
Interleukin-6
12%
Laboratory Measures
12%
Interleukin-4 (IL-4)
12%
Interleukin-1β
12%
Interleukin-10
12%
Disease Risk
12%
Between-group Difference
12%
Interleukin-2
12%
Anti-inflammatory Therapy
12%
Cognitive Assessment
12%
Prodromal
12%
Motor Assessment
12%
Disease Phenotype
12%
General Medical Conditions
12%
Treatment Assessment
12%
LRRK2 Gene
12%
Blood Fluid
12%
Dysregulated Immune Response
12%
GBA Gene
12%
Prodromal Phase
12%
Prodromal Parkinson's Disease
12%
Biochemistry, Genetics and Molecular Biology
LRRK2
100%
Cytokine
37%
Genetics
25%
Liquid
25%
Immune Response
12%
Interleukin 8
12%
Tumor Necrosis Factor
12%
Interleukin-1
12%
Interleukin-6
12%
Homozygote
12%
Neuroscience
Parkinson's Disease
100%
Anti-Inflammatory
7%
Neurodegeneration
7%
Genetics of Parkinson's Disease
7%